# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-25-060316
Filing Date
2025-04-29
Accepted
2025-04-29 17:05:04
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | eldn-2025-proxy-defa_14a.htm | DEFA14A | 27455
2 | GRAPHIC | img54275914_0.jpg | GRAPHIC | 545560
3 | GRAPHIC | img54275914_1.jpg | GRAPHIC | 267879
| Complete submission text file | 0000950170-25-060316.txt |  | 1148428

Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36620 | Film No.: 25889066
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)